Ivermectin Exeltis

Ivermectin, the active ingredient in Ivermectin Exeltis, is an anthelmintic presented as an oral formulation for systemic use. It is employed to treat parasitic infections such as onchocerciasis, strongyloidiasis, cutaneous larva migrans and scabies in affected patients.

GNH USA supplies Ivermectin Exeltis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution. Clients benefit from reliable logistics, batch traceability, and responsive technical support throughout the supply chain.

Ivermectin is an anthelmintic that targets parasitic infections affecting the skin and subcutaneous tissues.

Onchocerciasis: reduces microfilarial load and prevents disease progression. Strongyloidiasis: eliminates intestinal larvae and prevents hyperinfection. Cutaneous larva migrans: resolves migrating skin lesions caused by hookworm larvae. Scabies: eradicates Sarcoptes scabiei infestation and relieves itching.

Adverse reactions to Ivermectin Exeltis are generally mild, but serious events can occur.

Common Side Effects: - Nausea: mild stomach upset. - Diarrhea: loose stools. - Dizziness: transient light‑headedness. - Itching: mild skin pruritus.

Serious or Rare Side Effects: - Severe skin rash: including Stevens‑Johnson syndrome. - Liver injury: hepatitis or elevated liver enzymes. - Neurologic effects: seizures, altered consciousness, or visual disturbances.

When prescribing Ivermectin Exeltis, clinicians should consider several safety measures.

Assess contraindications: screen for known hypersensitivity to ivermectin. Review hepatic function: adjust use in patients with severe liver disease. Monitor for drug interactions: be aware of concomitant medications that may affect ivermectin levels. Use with caution in pregnancy: limited data, weigh benefits versus risks. Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Ivermectin may interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Warfarin: increased anticoagulant effect leading to bleeding risk. - Cyclosporine: elevated ivermectin concentrations causing toxicity.

Moderate Interactions (Monitor Closely): - Macrolide antibiotics (e.g., erythromycin): may increase ivermectin levels. - Anticonvulsants (e.g., carbamazepine): may reduce ivermectin efficacy. - HIV protease inhibitors (e.g., ritonavir): may raise ivermectin exposure.